Misplaced Pages

Revision as of 18:23, 10 October 2008

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Acne" – news · newspapers · books · scholar · JSTOR (October 2007) (Learn how and when to remove this message)

It has been suggested that acne scarring and acne scar treatment be merged into this article. (Discuss) Proposed since March 2008.

Acne
Specialty	Dermatology, family medicine

Acne vulgaris (commonly called acne) is a skin disease caused by changes in the pilosebaceous units (skin structures consisting of a hair follicle and its associated sebaceous gland). Severe acne is inflammatory, but acne can also manifest in noninflammatory forms. Acne lesions are commonly referred to as pimples, spots, zits, or bacne.

Acne is most common during adolescence, affecting more than 85% of teenagers, and frequently continues into adulthood. For most people, acne diminishes over time and tends to disappear—or at the very least decrease—after one reaches his or her early twenties. There is, however, no way to predict how long it will take to disappear entirely, and some individuals will continue to suffer well into their thirties, forties and beyond.

The face and upper neck are the most commonly affected, but the chest, back and shoulders may have acne as well. The upper arms can also have acne, but lesions found there are often keratosis pilaris, not acne. Typical acne lesions are comedones, inflammatory papules, pustules and nodules. Some of the large nodules were previously called "cysts" and the term nodulocystic has been used to describe severe cases of inflammatory acne.

Aside from scarring, its main effects are psychological, such as reduced self-esteem and, according to at least one study, depression or suicide. Acne usually appears during adolescence, when people already tend to be most socially insecure. Early and aggressive treatment is therefore advocated by some to lessen the overall impact to individuals.

Terminology

The term acne comes from a corruption of the Greek άκμή (acme in the sense of a skin eruption) in the writings of Aëtius Amidenus. Used by itself, the term "acne" refers to the presence of pustules and papules. The most common form of acne is known as "acne vulgaris", meaning "common acne". Many teenagers get this type of acne. Use of the term "acne vulgaris" implies the presence of comedones.

The term "acne rosacea" is a synonym for rosacea. Chloracne is associated with chlorine toxicity.

Causes of acne

Acne was originally meant to be used to warfare during World War Two against the Japanese, unfortunately it leaked out of it's containment facility, and young adults worldwide have had to deal with it. Acne develops as a result of blockages in follicles. Hyperkeratinization and formation of a plug of keratin and sebum (a microcomedo) is the earliest change. Enlargement of sebaceous glands and an increase in sebum production occur with increased androgen (DHEA-S) production at adrenarche. The microcomedo may enlarge to form an open comedo (blackhead) or closed comedo (whitehead). Whiteheads are the direct result of skin pores becoming clogged with sebum, a naturally occurring oil, and dead skin cells. In these conditions the naturally occurring largely commensual bacteria Propionibacterium acnes can cause inflammation, leading to inflammatory lesions (papules, infected pustules, or nodules) in the dermis around the microcomedo or comedo, which results in redness and may result in scarring or hyperpigmentation.

Primary causes

The root cause of why some people get acne and some do not is not fully known. It is known to be partly hereditary. Several factors are known to be linked to acne:

• Family/Genetic history. The tendency to develop acne runs in families. For example, school-age boys with acne often have other members in their family with acne as well. A family history of acne is associated with an earlier occurrence of acne and an increased number of retentional acne lesions.
• Hormonal activity, such as menstrual cycles and puberty. During puberty, an increase in male sex hormones called androgens cause the glands to get larger and make more sebum.
• Inflammation, skin irritation or scratching of any sort will activate inflammation. Anti-inflammatories are known to improve acne.
• Stress, through increased output of hormones from the adrenal (stress) glands, although modern tests have said otherwise and point to this not being a cause.
• Hyperactive sebaceous glands, secondary to the three hormone sources above.
• Accumulation of dead skin cells.
• Bacteria in the pores. Propionibacterium acnes (P. acnes) is the anaerobic bacterium that causes acne. In-vitro resistance of P. acnes to commonly used antibiotics has been increasing.
• Use of anabolic steroids.
• Any medication containing lithium, barbiturates or androgens.
• Exposure to certain chemical compounds. Chloracne is particularly linked to toxic exposure to dioxins, namely Chlorinated dioxins.
• Exposure to halogens. Halogen acne is linked to exposure to halogens (e.g. iodides, chlorides, bromides, fluorides).

Several hormones have been linked to acne: the androgens testosterone, dihydrotestosterone (DHT) and dehydroepiandrosterone sulfate (DHEAS), as well as insulin-like growth factor 1 (IGF-I). In addition, acne-prone skin has been shown to be insulin resistant .

Development of acne vulgaris in later years is uncommon, although this is the age group for Rosacea which may have similar appearances. True acne vulgaris in adult women may be a feature of an underlying condition such as pregnancy and disorders such as polycystic ovary syndrome or the rare Cushing's syndrome. Menopause-associated acne occurs as production of the natural anti-acne ovarian hormone estradiol fails at menopause. The lack of estradiol also causes thinning hair, hot flashes, thin skin, wrinkles, vaginal dryness, and predisposes to osteopenia and osteoporosis as well as triggering acne (known as acne climacterica in this situation).

Diet

Many patients hold the belief that their acne is influenced by dietary factors, while in previous decades, doctors thought that diet had little influence on acne. There is surprisingly little good scientific evidence to support or refute diet as a factor influencing acne. Most dermatologists are awaiting confirmatory research linking diet and acne but some support the idea that acne sufferers should experiment with their diets, and refrain from consuming such fare if they find such food affects the severity of their acne.

Milk

Recently, three epidemiological studies from the same group of scientists found an association between acne and consumption of partially skimmed milk, instant breakfast drink, sherbet, cottage cheese, and cream cheese. The researchers hypothesize that the association may be caused by hormones (such as several sex hormones and bovine insulin-like growth factor 1, IGF-1) or even iodine present in cow milk. Some but not all of these products survive digestion and could have biological effects in humans. Though there is evidence of an association between milk and acne, the exact cause remains unclear.

Carbohydrates

The long-held belief that there is no link between diets high in refined sugars and processed foods and acne has recently been challenged. The previous belief was based on earlier studies (some using chocolate and Coca Cola) that were methodologically flawed. The recent low glycemic-load hypothesis postulates that rapidly digested carbohydrate foods (such as soft drinks, sweets, white bread) produce an overload in blood glucose (hyperglycemia) that stimulates the secretion of insulin, which in turn triggers the release of IGF-1. IGF-1 has direct effects on the pilosebaceous unit (and insulin at high concentrations can also bind to the IGF-1 receptor) and has been shown to stimulate hyperkeratosis and epidermal hyperplasia. These events facilitate acne formation. Sugar consumption might also influence the activity of androgens via a decrease in sex hormone-binding globulin concentration.

In support of this hypothesis, a randomized controlled trial of a low glycemic-load diet improved acne and reduced weight, androgen activity and levels of insulin-like growth factor binding protein-1. High IGF-1 levels and mild insulin resistance (which causes higher levels of insulin) had previously been observed in patients with acne. High levels of insulin and acne are also both features of polycystic ovarian syndrome.

According to this hypothesis, the absence of acne in some non-Westernized societies could be explained by the low glycemic index of these cultures' diets. It is possible that genetic reasons account for there being no acne in these populations, although similar populations (such as South American Indians or Pacific Islanders) do develop acne. Note also that the populations studied consumed no milk or other dairy products.

Further research is necessary to establish whether a reduced consumption of high-glycemic foods, or treatment that results in increased insulin sensitivity (like metformin) can significantly alleviate acne, though consumption of high-glycemic foods should in any case be kept to a minimum, for general health reasons. Avoidance of junk food with its high fat and sugar content is also recommended.

Vitamins A and E

Studies have shown that newly diagnosed acne patients tend to have lower levels of vitamin A circulating in their bloodstream than those that are acne free. In addition people with severe acne also tend to have lower blood levels of vitamin E.

Hygiene

Acne is not caused by dirt. This misconception probably comes from the fact that blackheads look like dirt stuck in the openings of pores. The black color is not dirt but simply oxidised keratin. In fact, the blockages of keratin that cause acne occur deep within the narrow follicle channel, where it is impossible to wash them away. These plugs are formed by the failure of the cells lining the duct to separate and flow to the surface in the sebum created there by the body. Built up oil of the skin can block the passages of these pores, so standard washing of the face could wash off old oil and help unblock the pores.

Treatments

Available treatments

There are many products available for the treatment of acne, many of which are without any scientifically-proven effects. Generally speaking, successful treatments show little improvement within the first two weeks, instead taking a period of approximately three months to improve and start flattening out. Many treatments that promise big improvements within two weeks are likely to be largely disappointing. However, short bursts of cortisone can give very quick results, and other treatments can rapidly improve some active spots, but usually not all active spots.

Modes of improvement are not necessarily fully understood but in general treatments are believed to work in at least 4 different ways (with many of the best treatments providing multiple simultaneous effects):

• normalising shedding into the pore to prevent blockage
• killing P. acnes
• anti-inflammatory effects
• hormonal manipulation

A combination of treatments can greatly reduce the amount and severity of acne in many cases. Those treatments that are most effective tend to have greater potential for side effects and need a greater degree of monitoring, so a step-wise approach is often taken. Many people consult with doctors when deciding which treatments to use, especially when considering using any treatments in combination. There are a number of treatments that have been proven effective:

Topical bactericidals

Widely available OTC bactericidal products containing benzoyl peroxide may be used in mild to moderate acne. The gel or cream containing benzoyl peroxide is rubbed, twice daily, into the pores over the affected region. Bar soaps or washes may also be used and vary from 2 to 10% in strength. In addition to its therapeutic effect as a keratolytic (a chemical that dissolves the keratin plugging the pores) benzoyl peroxide also prevents new lesions by killing P.acnes. In one study, roughly 70% of participants using a 10% benzoyl peroxide solution experienced a reduction in acne lesions after 6 weeks.Unlike antibiotics, benzoyl peroxide has the advantage of being a strong oxidizer (essentially a mild bleach) and thus does not appear to generate bacterial resistance. However, it routinely causes dryness, local irritation and redness. A sensible regimen may include the daily use of low-concentration (2.5%) benzoyl peroxide preparations, combined with suitable non-comedogenic moisturisers to help avoid overdrying the skin.

Care must be taken when using benzoyl peroxide, as it can very easily bleach any fabric or hair it comes in contact with.

Other antibacterials that have been used include triclosan, or chlorhexidine gluconate but these are often less effective, but also have fewer side-effects.

Prescription-strength benzoyl peroxide preparations do not necessarily differ with regard to the maximum concentration of the active ingredient (10%), but the drug is made available dissolved in a vehicle that more deeply penetrates the pores of the skin.

Topical antibiotics

Externally applied antibiotics such as erythromycin, clindamycin, Stievamycin, or tetracycline kill the bacteria that are harbored in the blocked follicles. While topical use of antibiotics is equally as effective as oral use, this method avoids possible side effects including upset stomach and drug interactions (e.g. it will not affect use of the oral contraceptive pill), but may prove awkward to apply over larger areas than just the face alone.

Oral antibiotics

Oral antibiotics used to treat acne include erythromycin or one of the tetracycline antibiotics (tetracycline, the better absorbed oxytetracycline, or one of the once daily doxycycline, minocycline, or lymecycline). Trimethoprim is also sometimes used (off-label use in UK). However, reducing the P. acnes bacteria will not, in itself, do anything to reduce the oil secretion and abnormal cell behaviour that is the initial cause of the blocked follicles. Additionally the antibiotics are becoming less and less useful as resistant P. acnes are becoming more common. Acne will generally reappear quite soon after the end of treatment—days later in the case of topical applications, and weeks later in the case of oral antibiotics. Furthermore side effects of tetracycline antibiotics can include yellowing of the teeth and an imbalance of gut flora, so are only recommended after topical products have been ruled out.

It has been found that sub-antimicrobial doses of antibiotics such as minocycline also improve acne. It is believed that minocycline's anti-inflammatory effect also prevents acne. These low doses do not kill bacteria and hence cannot induce resistance.

Hormonal treatments

In females, acne can be improved with hormonal treatments. The common combined oestrogen/progestogen methods of hormonal contraception have some effect, but the antiandrogen, Cyproterone, in combination with an oestrogen (Diane 35) is particularly effective at reducing androgenic hormone levels. Diane-35 is not available in the USA, but a newer oral contraceptive containing the progestin drospirenone is now available with fewer side effects than Diane 35 / Dianette. Both can be used where blood tests show abnormally high levels of androgens, but are effective even when this is not the case. Along with this, treatment with low dose spironolactone can have anti-androgenetic properties, especially in patients with polycystic ovarian syndrome.

If a pimple is large and/or does not seem to be affected by other treatments, a dermatologist may administer an injection of cortisone directly into it, which will usually reduce redness and inflammation almost immediately. This has the effect of flattening the pimple, thereby making it easier to cover up with makeup, and can also aid in the healing process. Side effects are minimal, but may include a temporary whitening of the skin around the injection point; and occasionally a small depression forms, which may persist, although often fills eventually. This method also carries a much smaller risk of scarring than surgical removal.

Topical retinoids

A group of medications for normalizing the follicle cell lifecycle are topical retinoids such as tretinoin (brand name Retin-A), adapalene (brand name Differin), and tazarotene (brand name Tazorac). Like isotretinoin, they are related to vitamin A, but they are administered as topicals and generally have much milder side effects. They can, however, cause significant irritation of the skin. The retinoids appear to influence the cell creation and death lifecycle of cells in the follicle lining. This helps prevent the hyperkeratinization of these cells that can create a blockage. Retinol, a form of vitamin A, has similar but milder effects and is used in many over-the-counter moisturizers and other topical products. Effective topical retinoids have been in use over 30 years but are available only on prescription so are not as widely used as the other topical treatments. Topical retinoids often cause an initial flare up of acne and facial flushing.

Oral retinoids

A daily oral intake of vitamin A derivative isotretinoin (marketed as Accutane, Amnesteem, Sotret, Claravis, Clarus) over a period of 4-6 months can cause long-term resolution or reduction of acne. It is believed that isotretinoin works primarily by reducing the secretion of oils from the glands, however some studies suggest that it affects other acne-related factors as well. Isotretinoin has been shown to be very effective in treating severe acne and can either improve or clear well over 80% of patients. The drug has a much longer effect than anti-bacterial treatments and will often cure acne for good. The treatment requires close medical supervision by a dermatologist because the drug has many known side effects (many of which can be severe). About 25% of patients may relapse after one treatment. In those cases, a second treatment for another 4-6 months may be indicated to obtain desired results. It is often recommended that one lets a few months pass between the two treatments, because the condition can actually improve somewhat in the time after stopping the treatment and waiting a few months also gives the body a chance to recover. Occasionally a third or even a fourth course is used, but the benefits are often less substantial. The most common side effects are dry skin and occasional nosebleeds (secondary to dry nasal mucosa). Oral retinoids also often cause an initial flare up of acne within a month or so, which can be severe. There are reports that the drug has damaged the liver of patients. For this reason, it is recommended that patients have blood samples taken and examined before and during treatment. In some cases, treatment is terminated or reduced due to elevated liver enzymes in the blood, which might be related to liver damage. Others claim that the reports of permanent damage to the liver are unsubstantiated, and routine testing is considered unnecessary by some dermatologists. Blood triglycerides also need to be monitored. However, routine testing are part of the official guidelines for the use of the drug in many countries. Some press reports suggest that isotretinoin may cause depression but as of September 2005 there is no agreement in the medical literature as to the risk. The drug also causes birth defects if women become pregnant while taking it or take it while pregnant. For this reason, female patients are required to use two separate forms of birth control or vow abstinence while on the drug. Because of this, the drug is supposed to be given to females as a last resort after milder treatments have proven insufficient. Restrictive rules (see iPledge program) for use were put into force in the USA beginning in March 2006 to prevent misuse, causing occasioned widespread editorial comment.

Phototherapy

'Blue' and red light

It has long been known that short term improvement can be achieved with sunlight. However, studies have shown that sunlight worsens acne long-term . More recently, visible light has been successfully employed to treat acne (phototherapy) - in particular intense violet light (405-420nm) generated by purpose-built fluorescent lighting, dichroic bulbs, LEDs or lasers. Used twice weekly, this has been shown to reduce the number of acne lesions by about 64%; and is even more effective when applied daily. The mechanism appears to be that a porphyrin (Coproporphyrin III) produced within P. acnes generates free radicals when irradiated by 420nm and shorter wavelengths of light. Particularly when applied over several days, these free radicals ultimately kill the bacteria. Since porphyrins are not otherwise present in skin, and no UV light is employed, it appears to be safe, and has been licensed by the U.S. FDA. The treatment apparently works even better if used with red visible light (660 nanometer) resulting in a 76% reduction of lesions after 3 months of daily treatment for 80% of the patients; and overall clearance was similar or better than benzoyl peroxide. Unlike most of the other treatments few if any negative side effects are typically experienced, and the development of bacterial resistance to the treatment seems very unlikely. After treatment, clearance can be longer lived than is typical with topical or oral antibiotic treatments; several months is not uncommon. The equipment or treatment, however, is relatively new and reasonably expensive to buy initially, although the total cost of ownership can be similar to many other treatment methods (such as the total cost of benzoyl peroxide, moisturiser, washes) over a couple of years of use.

Photodynamic therapy

In addition, basic science and clinical work by dermatologists Yoram Harth and Alan Shalita and others has produced evidence that intense blue/violet light (405-425 nanometer) can decrease the number of inflammatory acne lesion by 60-70% in 4 weeks of therapy, particularly when the P.acnes is pretreated with delta-aminolevulinic acid (ALA), which increases the production of porphyrins. However this photodynamic therapy is controversial and apparently not published in a peer reviewed journal.

Laser treatment

Laser surgery has been in use for some time to reduce the scars left behind by acne, but research has been done on lasers for prevention of acne formation itself. The laser is used to produce one of the following effects:

• to burn away the follicle sac from which the hair grows
• to burn away the sebaceous gland which produces the oil
• to induce formation of oxygen in the bacteria, killing them

Since lasers and intense pulsed light sources cause thermal damage to the skin, there are concerns that laser or intense pulsed light treatments for acne will induce hyperpigmented macules (spots) or cause long-term dryness of the skin.

In the United States, the FDA has approved several companies, such as Candela Corp., to use a cosmetic laser for the treatment of acne. However, efficacy studies have used very small sample sizes (fewer than 100 subjects) for periods of six months or less, and have shown contradictory results. Also, laser treatment being relatively new, protocols remain subject to experimentation and revision, and treatment can be quite expensive. Also, some Smoothbeam laser devices had to be recalled due to coolant failure, which resulted in painful burn injuries to patients.

Less widely used treatments

• Aloe vera: there are treatments for acne mentioned in Ayurveda using herbs such as Aloe vera, Haldi (Turmeric) and Papaya. There is limited evidence from medical studies on these products. Products from Rubia cordifolia, Curcuma longa (commonly known as Turmeric), Hemidesmus indicus (known as ananthamoola or anantmula), and Azadirachta indica (Neem) have been shown to have anti-inflammatory effects, but not aloe vera.
• Azelaic acid (brand names Azelex, Finevin and Skinoren) is suitable for mild, comedonal acne.
• Heat: local heating may be used to kill the bacteria in a developing pimple and so speed healing.
• Naproxen or ibuprofen are used for some moderate acne for their anti-inflammatory effect.
• Nicotinamide, (Vitamin B3) used topically in the form of a gel, has been shown in a 1995 study to be more effective than a topical antibiotic used for comparison, as well as having fewer side effects. Topical nicotinamide is available both on prescription and over-the-counter. The property of topical nicotinamide's benefit in treating acne seems to be its anti-inflammatory nature. It is also purported to result in increased synthesis of collagen, keratin, involucrin and flaggrin.
• Tea Tree Oil (Melaleuca Oil) dissolved in a carrier (5% strength) has been used with some success, where it is comparable to benzoyl peroxide but without excessive drying, kills P.Acnes, and has been shown to be an effective anti-inflammatory in skin infections.
• Rofecoxib was shown to improve premenstrual acne vulgaris in a placebo controlled study.
• Zinc: Orally administered zinc gluconate has been shown to be effective in the treatment of inflammatory acne, although less so than tetracyclines.
• Comedo extraction

History of some acne treatments

This section needs additional citations for verification. Please help improve this article by adding citations to reliable sources in this section. Unsourced material may be challenged and removed. (December 2007) (Learn how and when to remove this message)

The history of acne reaches back to the dawn of recorded history. In Ancient Egypt, it is recorded that several pharaohs were acne sufferers. From Ancient Greece comes the English word 'acne' (meaning 'point' or 'peak'). Acne treatments are also of considerable antiquity:

• Ancient Rome: bathing in hot, and often sulfurous, mineral water was one of the few available acne treatments. One of the earliest texts to mention skin problems is De Medicina by the Roman writer Celsus.
• 1800s: Nineteenth century dermatologists used sulphur in the treatment of acne. It was believed to dry the skin.
• 1920s: Benzoyl Peroxide is used
• 1930s: Laxatives were used as a cure for what were known as 'chastity pimples'. Radiation also was used.
• 1950s: When antibiotics became available, it was discovered that they had beneficial effects on acne. They were taken orally to begin with. Much of the benefit was not from killing bacteria but from the anti-inflammatory effects of tetracycline and its relatives. Topical antibiotics became available later.
• 1970s: Tretinoin (original Trade Name Retin A) was found effective for acne. This preceded the development of oral isotretinoin (sold as Accutane and Roaccutane) in 1980.
• 1980s: Accutane is introduced in America, and later found to be a teratogen, highly likely to cause birth defects if taken during pregnancy. In the United States more than 2,000 women became pregnant while taking the drug between 1982 and 2003, with most pregnancies ending in abortion or miscarriage. About 160 babies with birth defects were born.
• 1990s: Laser treatment introduced
• 2000s: Blue/red light therapy

Future treatments

A vaccine against inflammatory acne has been tested successfully in mice, but it is not certain that it would work similarly in humans. A 2007 microbiology article reporting the first genome sequencing of a Propionibacterium acnes bacteriophage (PA6) said this "should greatly enhance the development of a potential bacteriophage therapy to treat acne and therefore overcome the significant problems associated with long-term antibiotic therapy and bacterial resistance."

Preferred treatments by types of acne vulgaris

• Comedonal (non-inflammatory) acne: local treatment with azelaic acid, salicylic acid, topical retinoids, benzoyl peroxide.
• Mild papulo-pustular (inflammatory) acne: benzoyl peroxide or topical retinoids, topical antibiotics (such as erythromycin).
• Moderate inflammatory acne: benzoyl peroxide or topical retinoids combined with oral antibiotics (tetracyclines). Isotretinoin is an option.
• Severe inflammatory acne, nodular acne, acne resistant to the above treatments: isotretinoin also known as Accutane, can be prescribed by a doctor, or contraceptive pills with cyproterone for females with virilization or drospirenone.

Acne scars

See Acne scarring.

Acne often leaves small scars where the skin gets a "volcanic" shape.

Physical acne scars are often referred to as "Icepick" scars. This is because the scars tend to cause an indentation in the skin's surface. There are a range of treatments available. Although quite rare, the medical condition Atrophia Maculosa Varioliformis Cutis results in "acne like" depressed scars on the face.

Ice pick scars - Deep pits, that are the most common and a classic sign of acne scarring.
Box car scars - Angular scars that usually occur on the temple and cheeks, and can be either superficial or deep, these are similar to chickenpox scars.
Rolling scars - Scars that give the skin a wave-like appearance.
Hypertrophic scars - Thickened, or keloid scars.

Pigmentation

Pigmented scars is a slightly misleading term as it suggests a change in the skin's pigmentation and that they are true scars; however, neither is true. Pigmented scars are usually the result of nodular or cystic acne (the painful 'bumps' lying under the skin). They often leave behind an inflamed red mark. Often, the pigmentation scars can be avoided simply by avoiding aggravation of the nodule or cyst. When sufferers try to 'pop' cysts or nodules, pigmentation scarring becomes significantly worse, and may even bruise the affected area. Pigmentation scars nearly always fade with time taking between 3 months to two years to do so, although rarely can persist.

On the other hand, some people—particularly those with naturally tanned skin—do develop brown hyperpigmentation scars due to increased production of the pigment melanin. These too typically fade over time.

Grading scale

There are multiple grading scales for grading the severity of acne vulgaris, three of these being: Leeds acne grading technique: Counts and categorises lesions into inflammatory and non-inflammatory (ranges from 0-10.0). 'Cook's acne grading scale: Uses photographs to grade severity from 0 to 8 (0 being the least severe and 8 being the most severe). Pillsbury scale: Simply classifies the severity of the acne from 1 (least severe) to 4 (most severe).

See also

• Blackhead
• Keratosis pilaris
• Rosacea
• Chloracne
• Feline acne

References

1. eMedicine - Acne Vulgaris : Article by Julie C Harper
2. James WD (2005). "Clinical practice. Acne". N Engl J Med. 352 (14): 1463–72. PMID 15814882.
3. Anderson, Laurence. 2006. Looking Good, the Australian guide to skin care, cosmetic medicine and cosmetic surgery. AMPCo. Sydney. ISBN 0 85557 044 X.
4. Thiboutot, Diane M.; Strauss, John S. (2003). "Diseases of the sebaceous glands". In Burns, Tony; Breathnach, Stephen; Cox, Neil; Griffiths, Christopher (ed.). Fitzpatrick's dermatology in general medicine (6th ed. ed.). New York: McGraw-Hill. pp. pp. 672-87. ISBN 0-07-138076-0. {{cite book}}: |edition= has extra text (help); |pages= has extra text (help)CS1 maint: multiple names: authors list (link)
5. ^ Goodman G (2006). "Acne and acne scarring - the case for active and early intervention" (PDF). Aust Fam Physician. 35 (7): 503–4. PMID 16820822.
6. Purvis D, Robinson E, Merry S, Watson P (2006). "Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students". J Paediatr Child Health. 42 (12): 793–6. doi:10.1111/j.1440-1754.2006.00979.x. PMID 17096715.{{cite journal}}: CS1 maint: multiple names: authors list (link)
   One study has estimated the incidence of suicidal ideation in patients with acne as 7.1% :
   * Picardi A, Mazzotti E, Pasquini P (2006). "Prevalence and correlates of suicidal ideation among patients with skin disease". J Am Acad Dermatol. 54 (3): 420–6. doi:10.1016/j.jaad.2005.11.1103. PMID 16488292.{{cite journal}}: CS1 maint: multiple names: authors list (link)
7. "acne" at Dorland's Medical Dictionary
8. "acne vulgaris" at Dorland's Medical Dictionary
9. "acne rosacea" at Dorland's Medical Dictionary
10. Simpson, Nicholas B.; Cunliffe, William J. (2004). "Disorders of the sebaceous glands". In Burns, Tony; Breathnach, Stephen; Cox, Neil; Griffiths, Christopher (ed.). Rook's textbook of dermatology (7th ed. ed.). Malden, Mass.: Blackwell Science. pp. pp. 43.1-75. ISBN 0-632-06429-3. {{cite book}}: |edition= has extra text (help); |pages= has extra text (help)CS1 maint: multiple names: authors list (link)
11. F. Ballangera, P. Baudrya, J.M. N'Guyenb, A. Khammaria, B. Dréno Heredity: A Prognostic Factor for Acne 5/2/2005
12. US Dept Health and Human Services January 2005
13. National Guideline Clearinghouse 11/12/2007
14. ^ Keri JE, Nijhawan RI (2008). "Diet and acne". Expert Rev Dermatol. 3 (4): 437–440.
15. Magin P, Pond D, Smith W, Watson A (2005). "A systematic review of the evidence for 'myths and misconceptions' in acne management: diet, face-washing and sunlight". Fam Pract. 22 (1): 62–70. doi:10.1093/fampra/cmh715. PMID 15644386. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
16. Fries JH (1978). "Chocolate: a review of published reports of allergic and other deleterious effects, real or presumed". Ann Allergy. 41 (4): 195–207. PMID 152075.
17. Adebamowo CA, Spiegelman D, Danby FW, Frazier AL, Willett WC, Holmes MD (2005). "High school dietary dairy intake and teenage acne". J Am Acad Dermatol. 52 (2): 207–14. doi:10.1016/j.jaad.2004.08.007. PMID 15692464.{{cite journal}}: CS1 maint: multiple names: authors list (link)
18. Adebamowo CA, Spiegelman D, Berkey CS; et al. (2008). "Milk consumption and acne in teenaged boys". J. Am. Acad. Dermatol. 58 (5): 787–93. doi:10.1016/j.jaad.2007.08.049. PMID 18194824. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
19. Adebamowo CA, Spiegelman D, Berkey CS; et al. (2006). "Milk consumption and acne in adolescent girls". Dermatol. Online J. 12 (4): 1. PMID 17083856. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
20. Arbesman H (2005). "Dairy and acne--the iodine connection". J. Am. Acad. Dermatol. 53 (6): 1102. doi:10.1016/j.jaad.2005.05.046. PMID 16310091. {{cite journal}}: Unknown parameter |month= ignored (help)
21. Fulton JE, Plewig G, Kligman AM (1969). "Effect of chocolate on acne vulgaris". JAMA. 210 (11): 2071–4. PMID 4243053. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
22. Anderson PC (1971). "Foods as the cause of acne". Am Fam Physician. 3 (3): 102–3. PMID 4251510. {{cite journal}}: Unknown parameter |month= ignored (help)
23. Deplewski D, Rosenfield RL (2000). "Role of hormones in pilosebaceous unit development". Endocr. Rev. 21 (4): 363–92. PMID 10950157. {{cite journal}}: Unknown parameter |month= ignored (help)
24. DiGiovanni J, Bol DK, Wilker E; et al. (2000). "Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion". Cancer Res. 60 (6): 1561–70. PMID 10749124. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
25. Smith R, Mann N, Mäkeläinen H, Roper J, Braue A, Varigos G (2008). "A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial". Mol Nutr Food Res. 52 (6): 718–26. doi:10.1002/mnfr.200700307. PMID 18496812. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
26. Selva DM, Hogeveen KN, Innis SM, Hammond GL (2007). "Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene". J. Clin. Invest. 117 (12): 3979–87. doi:10.1172/JCI32249. PMC 2066187. PMID 17992261. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
27. Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA (2007). "The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial". J. Am. Acad. Dermatol. 57 (2): 247–56. doi:10.1016/j.jaad.2007.01.046. PMID 17448569. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
28. Aizawa H, Niimura M (1995). "Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne". J. Dermatol. 22 (4): 249–52. PMID 7608381. {{cite journal}}: Unknown parameter |month= ignored (help)
29. Cappel M, Mauger D, Thiboutot D (2005). "Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women". Arch Dermatol. 141 (3): 333–8. doi:10.1001/archderm.141.3.333. PMID 15781674. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
30. Aizawa H, Niimura M (1996). "Mild insulin resistance during oral glucose tolerance test (OGTT) in women with acne". J. Dermatol. 23 (8): 526–9. PMID 8854583. {{cite journal}}: Unknown parameter |month= ignored (help)
31. Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J (2002). "Acne vulgaris: a disease of Western civilization". Arch Dermatol. 138 (12): 1584–90. PMID 12472346. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
32. Freyre EA, Rebaza RM, Sami DA, Lozada CP (1998). "The prevalence of facial acne in Peruvian adolescents and its relation to their ethnicity". J Adolesc Health. 22 (6): 480–4. PMID 9627819. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
33. Fleischer AB, Feldman SR, Bradham DD (1994). "Office-based physician services provided by dermatologists in the United States in 1990". J. Invest. Dermatol. 102 (1): 93–7. PMID 8288916. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
34. Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J (2002). "Acne vulgaris: a disease of Western civilization". Arch Dermatol. 138 (12): 1584–90. PMID 12472346.{{cite journal}}: CS1 maint: multiple names: authors list (link)
35. Smith R, Mann N, Makelainen H, Braue A, Varigos G (2004). "The effect of short-term altered macronutrient status on acne vulgaris and biochemical markers of insulin sensitivity". Asia Pac J Clin Nutr. 13 (Suppl): S67. PMID 15294556.{{cite journal}}: CS1 maint: multiple names: authors list (link)
36. Anderson, Laurence. 2006. Looking Good, the Australian guide to skin care, cosmetic medicine and cosmetic surgery. AMPCo. Sydney. ISBN 0-85557-044-X.
37. Naweko San-Joyz (2007-04-11). "How Does Vitamin A Prevent Acne Outbreaks?". American Chronical. Retrieved 2007-09-17.
38. El-Akawi Z, Abdel-Latif N, Abdul-Razzak K (2006). "Does the plasma level of vitamins A and E affect acne condition?". Clin. Exp. Dermatol. 31 (3): 430–4. doi:10.1111/j.1365-2230.2006.02106.x. PMID 16681594.{{cite journal}}: CS1 maint: multiple names: authors list (link)
39. Comparative evaluation of retinoic acid, benzoyl peroxide and erythromycin lotion in acne vulgarils
40. Bernadine Healy (2005-05-09). "Pledging for Accutane". US News Best Health. {{cite news}}: Check date values in: |date= (help)
41. Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezuka T (2002). "Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation". J Dermatol Sci. 30 (2): 129–35. doi:10.1016/S0923-1811(02)00068-3. PMID 12413768.{{cite journal}}: CS1 maint: multiple names: authors list (link)
42. Kjeldstad B (1984). "Photoinactivation of Propionibacterium acnes by near-ultraviolet light". Z Naturforsch . 39 (3–4): 300–2. PMID 6730638.
43. Ashkenazi H, Malik Z, Harth Y, Nitzan Y (2003). "Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light". FEMS Immunol Med Microbiol. 35 (1): 17–24. doi:10.1111/j.1574-695X.2003.tb00644.x. PMID 12589953.{{cite journal}}: CS1 maint: multiple names: authors list (link)
44. "New Light Therapy for Acne" U.S. Food and Drug Administration, FDA Consumer magazine, November-December 2002 Notice
45. Papageorgiou P, Katsambas A, Chu A (2000). "Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris". Br J Dermatol. 142 (5): 973–8. doi:10.1046/j.1365-2133.2000.03481.x. PMID 10809858.{{cite journal}}: CS1 maint: multiple names: authors list (link)
46. BBC NEWS | Health | Doubts over acne laser treatment
47. Manage Account - Modern Medicine
48. Enforcement Report for January 14, 2004
49. ^ Mantle D, Gok MA, Lennard TW (2001). "Adverse and beneficial effects of plant extracts on skin and skin disorders". Adverse drug reactions and toxicological reviews. 20 (2): 89–103. PMID 11482001.{{cite journal}}: CS1 maint: multiple names: authors list (link)
50. Jain A, Basal E (2003). "Inhibition of Propionibacterium acnes-induced mediators of inflammation by Indian herbs". Phytomedicine. 10 (1): 34–8. doi:10.1078/094471103321648638. PMID 12622461.
51. http://journals.tubitak.gov.tr/medical/issues/sag-00-30-5/sag-30-5-14-97076.pdf
52. S. Bruce1, C. Conrad, R. D. Peterson, R. Conrad, L. S. Arambide, J. Thompson, and W. Klemp. "Significant Efficacy and Safety of Low Level Intermittent Heat in Patients with Mild to Moderate Acne" (PDF). Retrieved 2008-03-09.{{cite web}}: CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link)
53. Shalita A, Smith J, Parish L, Sofman M, Chalker D (1995). "Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris". Int J Dermatol. 34 (6): 434–7. doi:10.1111/j.1365-4362.1995.tb04449.x. PMID 7657446.{{cite journal}}: CS1 maint: multiple names: authors list (link)
54. Koh KJ, Pearce AL, Marshman G, Finlay-Jones JJ, Hart PH (2002). "Tea tree oil reduces histamine-induced skin inflammation". Br. J. Dermatol. 147 (6): 1212–7. doi:10.1046/j.1365-2133.2002.05034.x. PMID 12452873.{{cite journal}}: CS1 maint: multiple names: authors list (link)
55. Khalil Z, Pearce AL, Satkunanathan N, Storer E, Finlay-Jones JJ, Hart PH (2004). "Regulation of wheal and flare by tea tree oil: complementary human and rodent studies". J. Invest. Dermatol. 123 (4): 683–90. doi:10.1111/j.0022-202X.2004.23407.x. PMID 15373773.{{cite journal}}: CS1 maint: multiple names: authors list (link)
56. Tehrani R, Dharmalingam M (2004). "Management of premenstrual acne with Cox-2 inhibitors: A placebo controlled study". Indian J Dermatol Venereol Leprol . 70: 345–348. Retrieved 2007-06-23.
57. Dreno B, Amblard P, Agache P, Sirot S, Litoux P (1989). "Low doses of zinc gluconate for inflammatory acne". Acta Derm Venereol. 69 (6): 541–3. PMID 2575335.{{cite journal}}: CS1 maint: multiple names: authors list (link)
58. Dreno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C, Bodokh I, Chivot M, Daniel F, Humbert P, Meynadier J, Poli F (2001). "Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris". Dermatology. 203 (2): 135–40. doi:10.1159/000051728. PMID 11586012.{{cite journal}}: CS1 maint: multiple names: authors list (link)
59. "Tretinoin (retinoic acid) in acne". The Medical letter on drugs and therapeutics. 15 (1): 3. 1973. PMID 4265099.
60. Jones H, Blanc D, Cunliffe WJ (1980). "13-cis retinoic acid and acne". Lancet. 2 (8203): 1048–9. PMID 6107678.{{cite journal}}: CS1 maint: multiple names: authors list (link)
61. Bérard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D (2007). "Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective". British journal of clinical pharmacology. 63 (2): 196–205. doi:10.1111/j.1365-2125.2006.02837.x. PMID 17214828.{{cite journal}}: CS1 maint: multiple names: authors list (link)
62. Holmes SC, Bankowska U, Mackie RM (1998). "The prescription of isotretinoin to women: is every precaution taken?". Br. J. Dermatol. 138 (3): 450–5. doi:10.1046/j.1365-2133.1998.02123.x. PMID 9580798.{{cite journal}}: CS1 maint: multiple names: authors list (link)
63. Kim J (2008). "Acne vaccines: therapeutic option for the treatment of acne vulgaris?". J Invest Dermatol. 128 (10): 2353–4. doi:10.1038/jid.2008.221. PMID 18787542.
64. Farrar MD, Howson KM, Bojar RA, West D, Towler JC, Parry J, Pelton K, Holland KT (2007). "Genome sequence and analysis of a Propionibacterium acnes bacteriophage" (PDF). J Bacteriol. 189 (11): 4161–7. doi:10.1128/JB.00106-07. PMID 17400737.{{cite journal}}: CS1 maint: multiple names: authors list (link)
65. Leeds, Cook's and Pillsbury scales obtained from here

Further reading

Review articles and guidelines

• Webster GF (2002). "Acne vulgaris" (PDF). BMJ. 325 (7362): 475–9. PMID 12202330.
• Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR, Thiboutot D; Global Alliance to Improve Outcomes in Acne (2003). "Management of acne: a report from a Global Alliance to Improve Outcomes in Acne". J Am Acad Dermatol. 49 (1 Suppl): S1–37. PMID 12833004.{{cite journal}}: CS1 maint: multiple names: authors list (link)
• Feldman S, Careccia RE, Barham KL, Hancox J (2004). "Diagnosis and treatment of acne" (PDF). Am Fam Physician. 69 (9): 2123–30. PMID 15152959.{{cite journal}}: CS1 maint: multiple names: authors list (link)
• Haider A, Shaw JC (2004). "Treatment of acne vulgaris" (PDF). JAMA. 292 (6): 726–35. doi:10.1001/jama.292.6.726. PMID 15304471.
• Katsambas AD, Cunliffe WJ (eds.) (2004). "Acne and its treatment". Clin Dermatol. 22 (5): 359–447. doi:10.1016/j.clindermatol.2004.03.003. {{cite journal}}: |author= has generic name (help)
• James WD (2005). "Clinical practice. Acne". N Engl J Med. 352 (14): 1463–72. PMID 15814882.
• "Drugs for acne, rosacea and psoriasis". Treat Guidel Med Lett. 3 (35): 49–56. 2005. PMID 15961971.
• Sinclair W, Jordaan HF; Global Alliance to Improve Outcomes in Acne (2005). "Acne guideline 2005 update" (PDF). S Afr Med J. 95 (11 Pt 2): 881–92. PMID 16344888.{{cite journal}}: CS1 maint: multiple names: authors list (link)
• Zaenglein AL, Thiboutot DM (2006). "Expert committee recommendations for acne management" (PDF). Pediatrics. 118 (3): 1188–99. doi:10.1542/peds.2005-2022. PMID 16951015.
• Purdy S, de Berker D (2006). "Acne". BMJ. 333 (7575): 949–53. doi:10.1136/bmj.38987.606701.80. PMID 17082546.
• Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, Thiboutot DM, Van Voorhees AS, Beutner KA, Sieck CK, Bhushan R; American Academy of Dermatology/American Academy of Dermatology Association (2007). "Guidelines of care for acne vulgaris management". J Am Acad Dermatol. 56 (4): 651–63. doi:10.1016/j.jaad.2006.08.048. PMID 17276540.{{cite journal}}: CS1 maint: multiple names: authors list (link)

Reference books and chapters

• Plewig, Gerd; Kligman, Albert M. (2000). Acne and rosacea (3rd ed. ed.). New York: Springer-Verlag. ISBN 3-540-66751-2. {{cite book}}: |edition= has extra text (help)CS1 maint: multiple names: authors list (link)
• Cunliffe, William J.; Gollnick, Harald P. M. (2001). Acne : diagnosis and management. London: Martin Dunitz. ISBN 1-85317-206-5.{{cite book}}: CS1 maint: multiple names: authors list (link)
• Thiboutot, Diane M.; Strauss, John S. (2003). "Diseases of the sebaceous glands". In Burns, Tony; Breathnach, Stephen; Cox, Neil; Griffiths, Christopher (ed.). Fitzpatrick's dermatology in general medicine (6th ed. ed.). New York: McGraw-Hill. pp. pp. 672-87. ISBN 0-07-138076-0. {{cite book}}: |edition= has extra text (help); |pages= has extra text (help)CS1 maint: multiple names: authors list (link)
• Zaenglein, Andrea L.; Thiboutot, Diane M. (2003). "Acne vulgaris". In Bolognia, Jean L.; Jorizzo, Joseph L.; Rapini, Ronald P. (eds.) (ed.). Dermatology. London: Mosby. pp. pp. 531-44. ISBN 0-32302-4092. {{cite book}}: |editor= has generic name (help); |pages= has extra text (help)CS1 maint: multiple names: authors list (link)
• Habif, Thomas P. (2004). "Acne, rosacea, and related disorders". Clinical dermatology : a color guide to diagnosis and therapy (4th ed. ed.). Edinburgh: Mosby. pp. pp. 162-208. ISBN 0-323-01319-8. {{cite book}}: |edition= has extra text (help); |pages= has extra text (help)
• Simpson, Nicholas B.; Cunliffe, William J. (2004). "Disorders of the sebaceous glands". In Burns, Tony; Breathnach, Stephen; Cox, Neil; Griffiths, Christopher (ed.). Rook's textbook of dermatology (7th ed. ed.). Malden, Mass.: Blackwell Science. pp. pp. 43.1-75. ISBN 0-632-06429-3. {{cite book}}: |edition= has extra text (help); |pages= has extra text (help)CS1 maint: multiple names: authors list (link)
• James, William D.; Berger, Timothy G.; Elston, Dirk M. (2006). "Acne". Andrews' diseases of the skin : clinical dermatology (10th ed. ed.). Philadelphia: Saunders Elsevier. pp. pp. 231-50. ISBN 0-7216-2921-0. {{cite book}}: |edition= has extra text (help); |pages= has extra text (help)CS1 maint: multiple names: authors list (link)

External links

• Acne vulgaris: more than skin deep (on the psychological effects of acne)
• Acne photo library at Dermnet
• Story on Acne from the Better Health Channel (Quality assured by the Victorian government, Australia)
• "AcneNet". American Academy of Dermatology. - Dermatologist-reviewed information about acne.
• Q&A about Acne, from the National Institutes of Health.

• Articles to be merged from March 2008
• Skin diseases
• Dermatology